In this launch episode of our new ‘Life sciences in the spotlight’ podcast series, Dr Pamela Walker, partner and life sciences lead at Gate One, explores the critical dynamics of pharmaceutical companies’ patient engagement efforts in a shifting COVID-19 landscape. Pamela speaks to Novo Nordisk’s VP global marketing, Ozempic, Victoza and cardiovascular marketing development, Matyas Lakatos, and the global brand lead for Ozempic, Oren Yellinek. Gate One works with Novo Nordisk as a business transformation partner to support patient engagement initiatives across the business.
At Gate One, we tackle your toughest challenges and accelerate your boldest ambitions. Our mission is to deliver meaningful change.